Skip to main content
. 2021 May 17;4(5):e2110314. doi: 10.1001/jamanetworkopen.2021.10314

Table 3. Patients With Diagnosis of IS at Hospital Discharge Stratified by Presence of IS Diagnosis at Admission.

Variable Patients, No./total No. (%)
Control (n = 165 912)a Non–COVID-19 (n = 111 418)b P valuec COVID-19 (n = 5517)d P valuee
IS
Present at admission 150 112/165 912 (90.5) 100 360/111 418 (90.1) <.001 3634/5517 (65.9) <.001
Not present at admission 15 800/165 912 (9.5) 11 058/111 418 (9.9) <.001 1883/5517 (34.1) <.001
In-hospital death
IS present at admission 7242/150 112 (4.8) 5018/100 360 (5.0) .046 673/3634 (18.5) <.001
IS not present at admission 3394/15 800 (21.5) 2526/11 058 (22.8) .008 867/1883 (46.0) <.001
Favorable discharge
IS present at admission 103 477/150 112 (68.9) 72 487/100 360 (72.2) <.001 1738/3634 (47.8) <.001
IS not present at admission 5781/15 800 (36.6) 4384/11 058 (39.6) <.001 377/1883 (20.0) <.001
Received IV alteplase
IS present at admission 11 281/150 112 (7.5) 7304/100 360 (7.3) .10 200/3634 (5.5) <.001
IS not present at admission 566/15 800 (3.6) 371/11 058 (3.4) .37 80/1883 (4.2) .13
Received EVT
IS present at admission 9994/150 112 (6.7) 7259/100 360 (7.2) <.001 254/3634 (7.0) .43
IS not present at admission 607/15 800 (3.8) 425/11 058 (3.8) >.99 36/1883 (1.9) <.001

Abbreviations: EVT, endovascular thrombectomy; IS, ischemic stroke; IV, intravenous.

a

The control group comprised patients with IS who were discharged in 2019.

b

The non–COVID-19 group comprised patients with IS who did not have COVID-19 and were discharged between April and December 2020.

c

P values for non–COVID-19 group vs control group.

d

The COVID-19 group comprised patients with IS who had COVID-19 and were discharged between April and December 2020.

e

P values for COVID-19 group vs control group.